Llorca, Pierre-Michel

Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression

Reif, A., Bitter, I., Buyze, J., Cebulla, K., Frey, R., Fu, D.-J., Ito, T., Kambarov, Y., Llorca, P.-M., Oliveira-Maia, A. J., et al. (2023) · New England Journal of Medicine

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 222

COVID-19 pandemic lockdown and problematic eating behaviors in a student population

Flaudias, V., Iceta, S., Zerhouni, O., Rodgers, R. F., Billieux, J., Llorca, P.-M., Boudesseul, J., de Chazeron, I., Romo, L., Maurage, P., et al. (2020) · Journal of Behavioral Addictions

Eating Disorders and BehaviorsNutrition, Health and Food Behavior

Cited by 193

Guidelines for the use and management of long-acting injectable antipsychotics in serious mental illness

Llorca, P. M., Abbar, M., Courtet, P., Guillaume, S., Lancrenon, S., & Samalin, L. (2013) · BMC Psychiatry

Schizophrenia research and treatmentPsychiatric care and mental health services

Cited by 188

Ketamine for the acute treatment of severe suicidal ideation: double blind, randomised placebo controlled trial

Abbar, M., Demattei, C., El-Hage, W., Llorca, P.-M., Samalin, L., Demaricourt, P., Gaillard, R., Courtet, P., Vaiva, G., Gorwood, P., et al. (2022) · BMJ

Treatment of Major DepressionSuicide and Self-Harm Studies

Cited by 181

Validity study of Kessler's psychological distress scales conducted among patients admitted to French emergency department for alcohol consumption‐related disorders

Arnaud, B., Malet, L., Teissedre, F., Izaute, M., Moustafa, F., Geneste, J., Schmidt, J., Llorca, P., & Brousse, G. (2010) · Alcoholism: Clinical and Experimental Research

Substance Abuse Treatment and OutcomesAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 104

Stigmatization toward People with Anorexia Nervosa, Bulimia Nervosa, and Binge Eating Disorder: A Scoping Review

Brelet, L., Flaudias, V., Désert, M., Guillaume, S., Llorca, P.-M., & Boirie, Y. (2021) · Nutrients

Eating Disorders and BehaviorsObesity and Health Practices

Cited by 94

Benzodiazepine dependence: Focus on withdrawal syndrome

Authier, N., Balayssac, D., Sautereau, M., Zangarelli, A., Courty, P., Somogyi, A. A., Vennat, B., Llorca, P.-M., & Eschalier, A. (2009) · Annales Pharmaceutiques Françaises

Substance Abuse Treatment and OutcomesPharmaceutical Practices and Patient Outcomes

Cited by 79

Medication adherence in schizophrenia: The role of insight, therapeutic alliance and perceived trauma associated with psychiatric care

Tessier, A., Boyer, L., Husky, M., Baylé, F., Llorca, P.-M., & Misdrahi, D. (2017) · Psychiatry Research

Medication Adherence and ComplianceSchizophrenia research and treatment

Cited by 64

Metabolic and psychiatric effects of acyl coenzyme A binding protein (ACBP)/diazepam binding inhibitor (DBI)

Joseph, A., Moriceau, S., Sica, V., Anagnostopoulos, G., Pol, J., Martins, I., Lafarge, A., Maiuri, M. C., Leboyer, M., Loftus, J., et al. (2020) · Cell Death & Disease

Regulation of Appetite and ObesityEating Disorders and Behaviors

Cited by 44

Childhood maltreatment and clinical severity of treatment‐resistant depression in a French cohort of outpatients (FACE‐DR): One‐year follow‐up

Yrondi, A., Aouizerate, B., Bennabi, D., Richieri, R., D'Amato, T., Bellivier, F., Bougerol, T., Horn, M., Camus, V., Courtet, P., et al. (2020) · Depression and Anxiety

Child Abuse and TraumaTreatment of Major Depression

Cited by 37

Cannabis and Young Users—A Brief Intervention to Reduce Their Consumption (CANABIC): A Cluster Randomized Controlled Trial in Primary Care

Laporte, C., Vaillant-Roussel, H., Pereira, B., Blanc, O., Eschalier, B., Kinouani, S., Brousse, G., Llorca, P.-M., & Vorilhon, P. (2017) · The Annals of Family Medicine

Substance Abuse Treatment and OutcomesSmoking Behavior and Cessation

Cited by 36

Effects of depression and cognitive impairment on quality of life in older adults with schizophrenia spectrum disorder: results from a multicenter study.

Pascal de Raykeer, R., Hoertel, N., Blanco, C., Lavaud, P., Kaladjian, A., Blumenstock, Y., Cuervo-Lombard, C.-V., Peyre, H., Lemogne, C., Limosin, F., et al. (2019) · Journal of Affective Disorders

Schizophrenia research and treatmentAging, Health, and Disability

Cited by 35

Metabolic Syndrome and Illness Severity Predict Relapse at 1-Year Follow-Up in Schizophrenia: The FACE-SZ Cohort

Godin, O., Leboyer, M., Schürhoff, F., Llorca, P.-M., Boyer, L., Andre, M., Andrianarisoa, M., Aouizerate, B., Berna, F., Capdevielle, D., et al. (2018) · The Journal of Clinical Psychiatry

Schizophrenia research and treatmentMental Health and Psychiatry

Cited by 34

Patients’ adherence to smartphone apps in the management of bipolar disorder: a systematic review

Patoz, M.-C., Hidalgo-Mazzei, D., Pereira, B., Blanc, O., de Chazeron, I., Murru, A., Verdolini, N., Pacchiarotti, I., Vieta, E., Llorca, P.-M., et al. (2021) · International Journal of Bipolar Disorders

Digital Mental Health InterventionsMobile Health and mHealth Applications

Cited by 30

GC-MS determined cotinine in an epidemiological study on smoking status at delivery

Chazeron, I. D., Daval, S., Ughetto, S., Richard, D., Nicolay, A., Lemery, D., Llorca, P. M., & Coudoré, F. (2008) · Pulmonary Pharmacology & Therapeutics

Smoking Behavior and CessationPrenatal Substance Exposure Effects

Cited by 23

Clinical Decision-Making in the Treatment of Schizophrenia: Focus on Long-Acting Injectable Antipsychotics

Samalin, L., Garnier, M., Auclair, C., & Llorca, P.-M. (2016) · International Journal of Molecular Sciences

Schizophrenia research and treatmentMental Health Treatment and Access

Cited by 23

Improving social function with real-world social-cognitive remediation in schizophrenia: Results from the RemedRugby quasi-experimental trial

Dubreucq, J., Gabayet, F., Ycart, B., Faraldo, M., Melis, F., Lucas, T., Arnaud, B., Bacconnier, M., Bakri, M., Cambier, G., et al. (2020) · European Psychiatry

Schizophrenia research and treatmentAutism Spectrum Disorder Research

Cited by 20

Efficacy of esketamine nasal spray over quetiapine extended release over the short and long term: sensitivity analyses of ESCAPE-TRD, a randomised phase IIIb clinical trial

Young, A. H., Llorca, P.-M., Fagiolini, A., Falkai, P., Cardoner, N., Nielsen, R. E., Blomqvist, O., Godinov, Y., Rive, B., Diels, J., et al. (2025) · The British Journal of Psychiatry

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 9